Bharat Biotech Pact With Washington Varsity For Nasal Vaccine - Gulte

Hyderabad-based pharma giant, Bharat Biotech, entered into licensing agreement with the Washington University School of Medicine, in manufacturing the vaccine against Covid-19.

The Washington University is manufacturing nasal spray vaccine basing on the chimpanzee adenovirus.

Bharat Biotech chairman and MD Dr Krishna Ella said that their expertise in manufacturing the vaccine and distributing the same will help in taking it closer to the people.